Fant 9758 publikasjoner. Viser side 236 av 391:
Heavy metals and POP measurements 2022
This report presents an overview of the annual statistics and results from the monitoring programme of heavy metals and persistent organic pollutants (POPs) in EMEP in 2022.
NILU
2024
2000
2003
The health risk related to exposure to air pollution (fine particulate matter - PM2.5, ozone - O3, and nitrogen dioxide - NO2) in 2019 was estimated in terms of number of premature deaths and years of life lost related to exposure to for 41 European countries, including the 27 EU Member States. In 2019, air pollution continued to drive a significant burden of premature death and disease in the 41 countries reporting to EEA: 373,000 premature deaths were attributed to chronic exposure to PM2.5; 47,700 premature deaths were attributed to chronic NO2 exposure; 19,070 premature deaths were attributed to acute O3 exposure. The analysis on the EU’s progress to reach the 2030 target established in the Zero Pollution Action Plan shows a steady decrease in the number of premature deaths along the years, and if it continues to fall at a comparable rate in the future, then the target would be achieved by 2032. Had the new WHO air quality guideline level for PM2.5 of 5 µg/m3 been attained already in 2019 everywhere in Europe, the number of estimated premature deaths would have been at least 58 % lower. On the other hand, the attainment of the EU limit value for PM2.5 of 25 µg/m3 would have left the estimated number of premature deaths unchanged in EU-27.
ETC/ATNI
2021
This report presents the results of the environmental burden of disease (or health risk) assessment related to air pollution in 2021. The estimates include all-cause mortality and cause-specific mortality and morbidity health outcomes, with ten risk-outcome pairs considered for the cause-specific estimates. Cause-specific mortality and morbidity estimates are combined to allow assessing the overall impact on population health based on a common indicator, the disability-adjusted life year. Using estimates disaggregated by mortality and morbidity components allows for the identification of the related shares across European countries.
ETC/HE
2023
Health Risk Assessment of Air Pollution in Europe. Methodology description and 2017 results
This report describes the methodology applied to assess health risks across Europe in 2016, published in the European Environmental Agency’s Air Quality in Europe – 2019 report. The methodology applied is based on the work by de Leeuw and Horálek (2016), with a few adjustments. To estimate the health risk related to air pollution, the number of premature deaths and years of life lost related to exposure to fine particulate matter, ozone and nitrogen dioxide exposure were calculated for 41 countries across Europe. The results show that the largest health risks are estimated for the countries with the largest populations. However, in relative terms, when considering e.g., years of life lost per 100 000 inhabitants, the largest relative risks are observed in central and eastern European countries, and the lowest are found for the northern and north-western parts of Europe. Additionally to the assessment, a sensitivity analysis was undertaken to comprehend how much the presumed baseline concentration levels, the concentration below which no health effects are expected, affect the estimations. In addition, a benefit analysis, assuming attainment of the PM2.5 WHO guidelines across Europe, shows a reduction over 30 % of the 2017 premature deaths and years of life lost numbers.
ETC/ATNI
2020
Health Risk Assessment of Air Pollution and the Impact of the New WHO Guidelines
Air pollution is a major cause of premature death and disease and is the single largest environmental health risk in Europe. Heart disease and stroke are the most common reasons for premature deaths attributable to air pollution, followed by lung diseases and lung cancer.
The health risk assessment methodology assumptions have been recently adapted to follow the recommendations by the World Health Organisation (WHO), released in 2021. The new global air quality guidelines by WHO provide up-to-date health-based guideline levels for major health-damaging air pollutants and new recommendations for assessing the risk of exposure to air pollution.
This report estimates the health risk related to air pollution in 2020 based on the latest methodology. The estimates consider the number of premature deaths and years of life lost related to exposure to fine particulate matter, ozone and nitrogen dioxide, both for the 27 Member States of the European Union and for additional 14 European countries (Albania, Andorra, Bosnia and Herzegovina, Iceland, Kosovo, Liechtenstein, Monaco, Montenegro, North Macedonia, Norway, San Marino, Serbia, Switzerland, and Türkiye).
A sensitivity analysis to the changes in concentration-response functions and counterfactual concentrations is performed to understand the impact of such changes on the mortality outcome estimates. The sensitivity analysis included both old and new health risk methodology assumptions but also the recommendation from the ELAPSE study on the concentration response functions. The ELAPSE project includes some of the most recent studies on the health effects at low air pollution levels by examining associations between exposures to relatively low levels of air pollution across Europe, including levels below the current EU standards.
The results for 2020 show that the largest health risks are estimated for the countries with the largest populations. However, in relative terms, when considering e.g., years of life lost per 100 000 inhabitants, the largest relative risks are observed in central and eastern European countries for PM2.5, in central and southern European countries for NO2, and south and eastern European for O3. The lowest impact is found for the northern and north-western parts of Europe, where the concentrations are lowest. The number of premature deaths attributed to air pollution in 2020 compared to 2019, increased for PM2.5 and decreased for NO2 and O3. Apart from the changes in concentrations and demographics, the COVID-19 pandemics seems to also have an influence on these changes. For PM2.5, the reduction in concentrations were counteracted by the excess of deaths due to the pandemics. In the case of NO2, the reduction in concentrations was more pronounced as a result of the lockdown measures and the drastic reduction in traffic and its impact in reducing mortality was bigger than the increasing impact of excess of deaths due to COVID-19.
Changing assumptions on concentration-response functions and counterfactual concentrations have implications for estimating mortality health outcomes. The sensitivity analysis shows that it is not straightforward to assess which assumptions estimates the highest health impacts when both factors change. In this case, the final outcome will depend on the concentration at the grid-cell level. The latest assumptions are expected to reduce the health outcomes for PM2.5 and increase for NO2 and O3, when compared to the previous one. When aggregated to all countries, the health outcomes are reduced by over 40 % for PM2.5 and increased by 50 % and 30 % for NO2 and O3, respectively, in 2020. However, this change varies across countries depending on the concentration level the population in the individual countries is exposed to.
ETC/HE
2022
2013
Health implications of HBCD - results of an expert elicitation. NILU OR, 80/2010
2010